Status:
COMPLETED
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if it...
Detailed Description
Participants will be healthy volunteers or subjects with the diagnosis of hypertrophic cardiomyopathy (HCM). All patients will a undergo a one time; medical history, physical examination, questionnair...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adults with a diagnosis of HCM
- Able to consent
- Non-pregnant
- Healthy Controls free of hypertrophic cardiomyopathy and without a definitive family history of hypertrophic cardiomyopathy.
- Exclusion criteria:
- Decompensated Heart failure at time of enrollment (prior history of HF is not an exclusion criteria)
- Severe (known) Chronic obstructive pulmonary disease (COPD) (FEV1 between 30 and 50 percent of normal)
- Vulnerable study populations except for minorities (minorities may be targeted to achieve 25% minority recruitment required by the NIH)
- Pregnant women
- Children
Exclusion
Key Trial Info
Start Date :
November 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2024
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT03327623
Start Date
November 13 2017
End Date
June 21 2024
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905